Global Travelers Diarrhea Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Global Travelers Diarrhea Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • Globalinforesearch
  • January 2019
  • Pharmaceutical
  • 116 pages

Report Description

1
1
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Scope of the Report:
Travelers diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.
The classification of Travelers Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.
The worldwide market for Traveler's Diarrhea Therapeutics is expected to grow at a CAGR of roughly 7.1% over the next five years, will reach 890 million US$ in 2024, from 630 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Traveler's Diarrhea Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other

Market Segment by Applications, can be divided into
Adult Traveler's Diarrhea
Children Traveler's Diarrhea

There are 15 Chapters to deeply display the global Traveler's Diarrhea Therapeutics market.
Chapter 1, to describe Traveler's Diarrhea Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Traveler's Diarrhea Therapeutics, with sales, revenue, and price of Traveler's Diarrhea Therapeutics, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Traveler's Diarrhea Therapeutics, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Traveler's Diarrhea Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Traveler's Diarrhea Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Have query on this report?

Make an Enquiry
Table of Contents
1 Market Overview
1.1 Traveler's Diarrhea Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Immunization
List of Tables and Figures
Figure Traveler's Diarrhea Therapeutics Picture
Table Product Specifications of Traveler's Diarrhea Therapeutics
Figure Global Sales Market Share of Traveler's Diarrhea Therapeutics by Types in 2018
Table Traveler's Diarrhea Therapeutics Types for Major Manufacturers
Figure Immunization Picture

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074